# OnCo record capstan-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/capstan-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "capstan-therapeutics" ;
  schema:name "Capstan Therapeutics"@en ;
  schema:description "Capstan built a way to create CAR T cells inside the patient's body by delivering messenger RNA in targeted lipid nanoparticles, avoiding the need to manufacture cells outside the body. AbbVie bought it in 2025 for $2.1 billion."@en ;
  schema:url <https://onco.cc/companies/capstan-therapeutics/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.sec.gov/edgar/browse/?CIK=0002015437>, <https://www.sec.gov/Archives/edgar/data/1551152/000155115225000049/abbv-20250930.htm>, <https://www.sec.gov/Archives/edgar/data/1551152/000155115225000047/abbv-20250930xexhibit991.htm>, <https://www.sec.gov/edgar/browse/?CIK=0002015437> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/in-vivo-car-t/> ;
  onco:targets <https://onco.cc/targets/cd19/> .